CAROLINE HAMRICK: Open Payments
NPI 1225092398 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 11 payments from 8 companies in 2025. Trend: 2023 $702 · 2024 $681 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $90 |
| Dilon Technologies, Inc. | 1 | $63 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $21 |
| Smith+Nephew, Inc. | 1 | $19 |
| CONMED Corporation | 1 | $17 |
| EMD Serono, Inc. | 1 | $14 |
Products named: VENCLEXTA, HEMOBLAST BELLOWS, Lenvima, STRAVIX, EPKINLY, AIRSEAL.
Industry payments across GA — which companies pay providers there.
